Based in Japan and India. Has led to 1 successful fundraise in Japan. Been working the space of Venture Capital and Private Equity for the last 3 years.

The financing was led by HealthQuest Capital, with Arboretum Ventures and selected insiders joining the union. BioIQ will use funding to fuel continued growth and to support its mission to help transform the U. Oh, S Healthcare system and the impact of more than 100 million lives

“BioIQ is committed to helping all people to understand their health risks and to connect to personalized interventions. Our smart technology is fundamentally changing how individuals navigate the national healthcare system, resulting in greater convenience, improved access, higher quality outcomes and lower costs,” said Justin Bellante, CEO of BioIQ. “This capital gives us additional resources to strengthen and expand the value of our solutions to clients, further helping them move towards value-based care. “That’s right.

BioIQ works with some of the nation’s largest health plans, employers and health service providers, as well as a network of retail pharmacies, laboratories and responsible care organizations. These partnerships facilitate consumer navigation and secure exchange of health data—all part of a streamlined, simplified approach to closing the gap in care and preventive health testing. Since its launch in 2005, BioIQ has launched thousands of successful programs serving millions of participants.

Todd Creech, Partner at HealthQuest Capital, said, “We look forward to working with the BioIQ team and helping them achieve a new level of growth and success by providing quality care solutions for payers, providers and patients. “That’s right.

With this capital investment, BioIQ will continue to expand its reach to new markets and accelerate product and innovation growth. The dramatic growth of the company was driven by increased demand among health plans and employers’ organizations, including four of the five largest health plans in the U. Oh, S And many of Fortune 100’s leading companies

Paul McCreadie, Managing Director of Arboretum Ventures, said, “BioIQ has developed a unique solution to drive meaningful patient engagement across health care systems and providers to deliver better health outcomes at lower cost. We are thrilled to be partners in this exciting opportunity “That’s right.

With this investment, Todd Creech and Paul McCreadie joined the Board of Directors of BioIQ. Stifel acted as BioIQ’s exclusive financial advisor for financing

HealthQuest Capital
HealthQuest Capital makes early-growing investments in innovative commercial-scale healthcare companies that improve both patient outcomes and the healthcare economy. Investments focus on medical products, diagnostics, IT healthcare and technology-enabled healthcare services. HealthQuest’s investment team includes deep operational, clinical and scientific expertise and global relationships across the healthcare industry that can be leveraged to add value to its portfolio companies. HealthQuest Capital is headquartered in Belmont, California, with western coast and east coast offices. Find out more at www Healthcare capital Come on,

On the Arboretum Ventures
Arboretum Ventures is a venture capital company specializing in the healthcare sector. Founded in 2002, the company manages $450 million in four investment funds. The investment team focuses on capital-efficient companies that can significantly reduce healthcare costs and improve efficiency in the areas of focus on medical devices, diagnostics, IT healthcare and healthcare services. Arboretum is located in Ann Arbor, Michigan. More information can be found at www Arboretumvc: Come on,

On the BioIQ
BioIQ simplifies health testing for health plans, employers and businesses of all sizes and empowers people to take action to improve their health. The BioIQ Platform provides tools for organizing health testing programs and biometric screening events across multiple vendors, as well as multi-channel communication tools for engaging and motivating participants at every step of the way. BioIQ also provides a means to intervene when risks to chronic conditions are identified—a unified solution to keep at-risk populations up to date with health tests, along with risk management data analysis and resources to help people live their healthiest lives. Since 2005, BioIQ has launched thousands of successful health testing programs that serve millions of participants.

Please note that this piece of work originally appeared in English at https://www.vcnewsdaily.com/bioIQ/venture-funding.php. As Investocracy aims to bring global startup news and updates in both English and Japanese to you, it’s important that we attribute original source to you. If you have any questions/concerns please write to us at contact@investocracy.co

Leave a Reply

Your email address will not be published. Required fields are marked *